IL1B and COVID-19: Conversely, higher levels of IL-1β and IFN-γ at month 1, and MIP-1β, IL-1β, MIP-1α and IFN-γ at month 3, were observed among patients with mild/moderate diseases, compared to those with severe COVID-19.